Literature DB >> 15657346

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

Peyton T Taylor, Doris Haverstick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15657346     DOI： 10.1093/jnci/dji027

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer.

Authors:  Yingyan Han; Zhi Wang; Shujuan Sun; Zeyu Zhang; Jia Liu; Xin Jin; Peng Wu; Teng Ji; Wencheng Ding; Beibei Wang; Qinglei Gao
Journal:  Epigenetics       Date:  2019-09-03       Impact factor: 4.528

2.  Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.

Authors:  Adnen Faddaoui; Razan Sheta; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Stephane Gobeil; Chantale Morin; Karim Ghani; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

3.  Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer.

Authors:  Tian Yang; Mingwei Chen; Tianjun Chen; Asmitananda Thakur
Journal:  Oncol Lett       Date:  2015-07-24       Impact factor: 2.967

4.  Automated tracking of quantitative assessments of tumor burden in clinical trials.

Authors:  Daniel L Rubin; Debra Willrett; Martin J O'Connor; Cleber Hage; Camille Kurtz; Dilvan A Moreira
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

5.  Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Authors:  Zhi-Qiang Wang; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2014-01-30

6.  Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.

Authors:  Xin Ma; Lei Wang; Hongzhao Li; Yu Zhang; Yu Gao; Gang Guo; Kan Liu; Qingyu Meng; Chaofei Zhao; Dianjun Wang; Zhigang Song; Xu Zhang
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

7.  BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.

Authors:  Zhi-Qiang Wang; Adnen Faddaoui; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Chantal Guillemette; Stéphane Gobeil; Elizabeth Macdonald; Barbara Vanderhyden; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2015-10-13

8.  Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.

Authors:  Fei Wang; Xuelian Du; Xiaoxia Li; Naifu Liu; Hao Yu; Xiugui Sheng
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

9.  Concurrent preoperative chemotherapy and three-dimensional conformal radiotherapy followed by surgery for oral squamous cell carcinoma: a retrospective analysis of 104 cases.

Authors:  Lina Fan; Xuegang Hu; Shihan Lin; Wentu Zhou; Sheng Fu; Hongbing Lv
Journal:  Oncotarget       Date:  2017-04-21

10.  The efficacy and safety of apatinib in Ewing's sarcoma: a retrospective analysis in one institution.

Authors:  Yitian Wang; Li Min; Yong Zhou; Yi Luo; Hong Duan; Chongqi Tu
Journal:  Cancer Manag Res       Date:  2018-12-11       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.